Don Weissman, MD

Life Sciences and Healthcare

Medical and Regulatory Affairs

Strategic Business Development

Marketing & Communications 

KOL, HCP, C-Suite Relationships

Biopharmaceuticals, Technologies, Therapeutics

Telehealth, Genetics, Diagnostics, AI 

Clinical & Commercial Optimization

Patient Benefits and Values

Best Outcomes and Quality of Life

Patients, Providers, Caretakers




LifeSciences and Healthcare

Medical Science Liaison
Medical and Regulatory Affairs

Strategic Business Development

  Marketing, Communications, Transactions   


Proven track record helping Life Science Companies, 

 KOLs, Scientists, MDs, Entrepreneurs,

Clinical and Academic Institutions accelerate 

product utilization and commercial optimization,

growing market share and success for patient benefits,

with better outcomes and quality of life. 


Exceptional relationships, experience and success,  

communicating the benefits, values and differentials

building professional consensus.


Excellent Key Opinion Leader and HCP relationships

sharing insights, scientific exchange and HEOR

 to accelerate trials, applications, 

 adoption and advocacy.

Advisory Board Development, Honored Society

  and Management Relationships with LifeScience

  Corporations, University Medical Centers, 

Physicians of Influence, Regional and National

Decision Makers and Advocacy Groups.


Analyst, grant review and panel member:

The National Science Foundation, the NSF 

The National Institute of Health, the NIH and 

The Department of Health & Human Services, the HHS

Adept listener, articulate and persuasive, 
building professional consensus for 
applications, approvals, advocacy,
coverage and better outcomes.
Highly successful with the FDA, FTC, PhRMA, 
AHRQ and CMS. Proven track record of success for coverage
with government, insurance, payors and plans.

Honored society, academic and board relationships for strategic CME,
regional and national symposium, publications, communications,

 brand and market development, mobile and social media
for patient benefits and stakeholder values.


Extraordinary resources, knowledge and success

building and strengthening internal and external 

partnerships, alliances and goal realization.




Better therapeutics, diagnostics and services

to treat, ameliorate, cure and prevent.

To optimize patient well being and quality of life,

caretaker, provider and stakeholder values.

clinical, operational and economic outcomes.